{
  "alleleExist":false,
  "dataVersion":"v4.5",
  "diagnosticImplications":[],
  "diagnosticSummary":"",
  "geneExist":true,
  "geneSummary":"CDH1 (E-cadherin), a tumor suppressor involved in cell adhesion, is altered by mutation or deletion in various cancer typess, most frequently in breast and esophagogastric cancers.",
  "highestDiagnosticImplicationLevel":null,
  "highestFdaLevel":null,
  "highestPrognosticImplicationLevel":null,
  "highestResistanceLevel":null,
  "highestSensitiveLevel":null,
  "hotspot":false,
  "lastUpdate":"11/22/2020",
  "mutationEffect":{
    "citations":{
      "abstracts":[],
      "pmids":[
        "8934538",
        "17522512"
      ]
    },
    "description":"CDH1 truncating mutations can produce several forms of C-terminally truncated CDH1 proteins. These mutations have been found in breast cancer and as germline mutations in familial gastric cancer (PMID: 8934538, 17522512). CDH1 loss in a transplant mouse model demonstrated increased genomic instability and increased disease burden compared to wildtype (Abstract: Ishizawa, et al. ASH 2013, Abstract# 602 https://ashpublications.org/blood/article/122/21/344/83783/Loss-of-Function-of-The-Cell-Cycle-Regulator-Cdh1).",
    "knownEffect":"Likely Loss-of-function"
  },
  "oncogenic":"Likely Oncogenic",
  "otherSignificantResistanceLevels":[],
  "otherSignificantSensitiveLevels":[],
  "prognosticImplications":[],
  "prognosticSummary":"",
  "query":{
    "alteration":"D313Afs*43",
    "alterationType":null,
    "consequence":"frameshift_variant",
    "entrezGeneId":999,
    "hgvs":null,
    "hugoSymbol":"CDH1",
    "id":null,
    "proteinEnd":313,
    "proteinStart":313,
    "referenceGenome":"GRCh38",
    "svType":null,
    "tumorType":null
  },
  "treatments":[],
  "tumorTypeSummary":"",
  "variantExist":false,
  "variantSummary":"The CDH1 D313Afs*43 mutation is likely oncogenic.",
  "vus":false
}